title: Brief report: Validation of a quantitative HIV risk prediction tool using a national HIV testing cohort.
abstract: Routine screening is recommended for HIV detection. HIV risk estimation remains important. Our goal was to validate the Denver HIV Risk Score using a national cohort from the Centers for Disease Control and Prevention. Patients of 13 years and older were included, 4,830,941 HIV tests were performed, and 0.6% newly diagnosed infections were identified. Of all visits, 9% were very low risk (HIV prevalence = 0.20%), 27% low risk (HIV prevalence = 0.17%), 41% moderate risk (HIV prevalence = 0.39%), 17% high risk (HIV prevalence = 1.19%), and 6% very high risk (HIV prevalence = 3.57%). The Denver HIV Risk Score accurately categorized patients into different HIV risk groups.
authors.affiliation: *Department of Emergency Medicine, Denver Health Medical Center, Denver, CO; †Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, CO; ‡Department of Epidemiology, Colorado School of Public Health, Aurora, CO; §Department of Emergency Medicine, University of Cincinnati College of Medicine, Cincinnati, OH; ‖Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD; ¶Department of Emergency Medicine, Alameda County Medical Center, Oakland, CA; #Department of Emergency Medicine, University of California San Francisco, San Francisco, CA; **Denver Public Health, Denver, CO; ††University of Colorado College of Nursing, Aurora, CO; ‡‡Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO; §§Department of Patient Safety and Quality, Denver Health Medical Center, Denver, CO; ‖‖Department of Biostatistics and Informatics, Colorado School of Public Health, Aurora, CO; and ¶¶Department of Medicine, University of Colorado School of Medicine, Aurora, CO.
authors.forename: Jason S
authors.initials: JS
authors.lastname: Haukoos
authors.forename: Emily
authors.initials: E
authors.lastname: Hopkins
authors.forename: Meggan M
authors.initials: MM
authors.lastname: Bucossi
authors.forename: Michael S
authors.initials: MS
authors.lastname: Lyons
authors.forename: Richard E
authors.initials: RE
authors.lastname: Rothman
authors.forename: Douglas A E
authors.initials: DA
authors.lastname: White
authors.forename: Alia A
authors.initials: AA
authors.lastname: Al-Tayyib
authors.forename: Lucy
authors.initials: L
authors.lastname: Bradley-Springer
authors.forename: Jonathan D
authors.initials: JD
authors.lastname: Campbell
authors.forename: Allison L
authors.initials: AL
authors.lastname: Sabel
authors.forename: Mark W
authors.initials: MW
authors.lastname: Thrun
mesh_terms: D000293:Adolescent; D000328:Adult; D015331:Cohort Studies; D005260:Female; D015658:HIV Infections / Q000175:diagnosis* / Q000453:epidemiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D018570:Risk Assessment / Q000379:methods*; D055815:Young Adult